✦ LIBER ✦

Hæmorrhage per rectum as an indication of disease in a Meckel'S diverticulum

✍ Scribed by Judson T. Chesterman

Publisher: John Wiley and Sons
Year: 1935
Tongue: English
Weight: 522 KB
Volume: 23
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800239006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Massive hæmorrhage from a peptic ulcer i

Massive hæmorrhage from a peptic ulcer in a Meckel's Diverticulum in a female child of eleven months

✍ R. W. Wilkinson 📂 Article 📅 1947 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 1 views

Crohn’s disease in a Meckel’s diverticul

Crohn’s disease in a Meckel’s diverticulum: report of a case

✍ Ivan R. Diamond; Andrea Hayes-Jordan; M. James Phillips; Jacob C. Langer 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 266 KB

Crohn's disease of a meckel's diverticul

Crohn's disease of a meckel's diverticulum occurring in a case of jejunal diverticulitis

✍ D. Solomons; M. E. H. Halford 📂 Article 📅 1964 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

“Giant Meckel's diverticulum”: Report of

“Giant Meckel's diverticulum”: Report of an unusual case in a child with preoperative X-ray diagnosis

✍ R. B. Galifer; D. Noblet; J. L. Ferran 📂 Article 📅 1981 🏛 Springer-Verlag 🌐 English ⚖ 666 KB

Pyostomatitis vegetans as an oral manife

Pyostomatitis vegetans as an oral manifestation of Crohn's disease in a pediatric patient

✍ Fouseena Pazheri; Naim Alkhouri; Kadakkal Radhakrishnan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

A multicenter double-blind placebo-contr

A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to sinemet® in Parkinson's disease

✍ Dr. C. W. Olanow; S. Fahn; M. Muenter; H. Klawans; H. Hurtig; M. Stern; I. Shoul 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 778 KB

## Abstract Three hundred and seventy‐six subjects with advanced Parkinson's disease participated in a prospective, double‐blind placebo‐controlled study of the dopamine agonist pergolide mesylate as an adjunct to Sinemet®. At 6 months, patients randomized to pergolide had a statistically singnific